VAL vs. WRES, EQT, CRC, WEB, NBL, FTO, TXO, NBR, COP, and HAL
Should you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include W Resources (WRES), EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), 2059984 (FTO.L) (FTO), 282082 (TXO.L) (TXO), 60884 (NBR.L) (NBR), Casino, Guichard-Perrachon Societe Anonyme (COP), and HaloSource (HAL). These companies are all part of the "petroleum and natural gas" industry.
ValiRx vs.
ValiRx (LON:VAL) and W Resources (LON:WRES) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking.
In the previous week, ValiRx's average media sentiment score of 0.00 equaled W Resources'average media sentiment score.
ValiRx has a net margin of 0.00% compared to W Resources' net margin of -174.96%. W Resources' return on equity of -33.02% beat ValiRx's return on equity.
ValiRx has higher earnings, but lower revenue than W Resources. ValiRx is trading at a lower price-to-earnings ratio than W Resources, indicating that it is currently the more affordable of the two stocks.
ValiRx has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, W Resources has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.
W Resources received 164 more outperform votes than ValiRx when rated by MarketBeat users. Likewise, 73.88% of users gave W Resources an outperform vote while only 51.55% of users gave ValiRx an outperform vote.
4.6% of W Resources shares are owned by institutional investors. 18.3% of ValiRx shares are owned by company insiders. Comparatively, 28.0% of W Resources shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
W Resources beats ValiRx on 9 of the 12 factors compared between the two stocks.
Get ValiRx News Delivered to You Automatically
Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:VAL) was last updated on 1/21/2025 by MarketBeat.com Staff
